Carteolol is a quinolone and a secondary alcohol. Among its listed roles, it functions as a beta-adrenergic antagonist, an antihypertensive agent, an antiglaucoma drug, an anti-arrhythmia drug and a sympatholytic agent. It is the conjugate base of carteolol(1+). It is grouped under the following drug class(es): Beta blockers and Ophthalmic beta-blockers. Its therapeutic use is listed as ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Carteololum, 2(1H)-Quinolinone, 5-(3-((1, 1-dimethylethyl)amino)-2-hydroxypropoxy)-3 and 4-dihydro-. It is listed as a controlled drug substance. Its PubChem CID is 2583.
Carteolol
| CAS No | 51781-06-7 |
|---|---|
| Molecular Formula | C16H24N2O3 |
| Molecular Weight | 292.37 g/mol |
| Synonyms | 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Carteolol is a quinolone and a secondary alcohol. Among its listed roles, it functions as a beta-adrenergic antagonist, an antihypertensive agent, an antiglaucoma drug, an anti-arrhythmia drug and a sympatholytic agent.
The listed CAS number is 51781-06-7.
The listed molecular formula is C16H24N2O3.
The listed molecular weight is 292.37 g/mol.
5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one.
The source lists Carteololum, 2(1H)-Quinolinone, 5-(3-((1, 1-dimethylethyl)amino)-2-hydroxypropoxy)-3 and 4-dihydro-.